Market Access

Are you prepared for the Medicaid AMP cap removal starting January 1, 2024?

Currently, Medicaid rebates paid by drug manufacturers are capped at the quarterly Average Manufacturer’s Price (AMP) for each drug/biologic. The removal of the cap means ...

Patient Services

Patient Services Launch Diagnostic

Support programs have the power to drive patients to start, stay and succeed on therapy. These programs and the best practices that drive patient experience and access are critical to success.

Launch Excellence

Navigating a Drug Launch: Part 4 – The Launch Plan

Today there is a laser focus on product performance out of the gate, so there is a lot of pressure to get it right. This means pharma companies need to make sure that they have the right launch team in place before putting together the structure and tactics in their launch plans. Read to learn more.

Launch Excellence

Navigating a Drug Launch: Part 3 – How to execute

How can reps engage physicians beyond office visits in our digital world? Ultimately, this is what the launch teams need to answer when developing the ‘how to execute’ portion of their strategies.

Launch Excellence

Navigating a Drug Launch: Part 2 – How to Win

Pharma companies that have product launches that repeatedly perform beyond expectations know how to develop vision and positioning, create a brand strategy with notable differentiation, and focus on building superior customer experiences. Learn more.

Launch Excellence

Navigating a Drug Launch: Part 1 – Where to Play?

At Herspiegel, we have partnered with biotech and pharma companies big and small and have successfully brought millions of dollars worth of drugs, devices, and treatments to market. But before we get a product out the door, we help launch teams navigate their go-to-market strategies.

Market Access

Evidence Generation Strategy for a New Drug Formulation

A global pharmaceutical company worked with us to plan their European Union (EU) access strategy for a novel oncolytic drug based on a new formulation. Read the case study.

Market Access

Payer Value Proposition Development in a Crowded Disease Space

Our client, a mid-sized biopharmaceutical company, aimed to introduce a new asset into the highly competitive Parkinson's disease category. Read the case study.

Market Access

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

Read the article about the cost and supply challenges leading to Hospitals needing to start their own drug companies to lower generic drug prices.

Launch Excellence

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

Read about key lifecycle challenges for Biologic Manufacturers in this article.

Cell and Gene Therapy Commercialization Innovations

In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.

Launch Excellence

Complete Response Letters are Increasing

Complete Response Letters (CRLs) are increasing. How are pharma companies preparing? Read more.

Market Access

Government Intervention into Drug Pricing: Part Two

In this post, we discuss different approaches that aim to incite competition between branded and generic drug products, as well as an example demonstrating the potential impact of these policies.

Market Access

Government Intervention into Drug Pricing: Part One

This is the first in a four-part series where we will explore the issue of government intervention in drug costs. In this first post, we introduce a few commonly mentioned tactics, two of which we will dig deeper into in subsequent posts.

Medical Affairs

Development of a Scientific Platform for Biotech Client

Our biotech client was facing the challenge of introducing a new competitor into the market while simultaneously gaining a deeper understanding of their disease state. To navigate this complex scenario, they needed a strategic document that would serve as the foundation for both internal and external communications.

Medical Affairs

KOL Identification and Engagement Planning in Rare Disease Clinical Development

Our client, a leading biopharmaceutical company, sought to embark on a clinical development program within a new therapeutic area in the rare disease space. Read the case study.

Medical Affairs

Unveiling Insights: How KOLs Shaped a Groundbreaking Therapy’s Journey

A recent pivotal Phase 3 clinical trial marked a significant milestone for our client, a biopharmaceutical company, in their quest to introduce a novel treatment for major depressive disorder (MDD). Read more.

Roadmap to De-risk Commercialization of a Rare Disease Product

Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.

Market Access

CMS Announces First Drugs for Price Negotiations

The Centers for Medicare & Medicaid Services (CMS) just announced the first set of drugs and biologics for price negotiations to be effective 2026. Read the article to find out more.

Market Access

CMS Price Negotiations – Data Submission Update

Since CMS announced the first ten drugs selected for price negotiation on August 29th, 2023, primary manufacturers had until October 1st, 2023, to sign agreements to participate in the Price Negotiation Program. Read the article to find out more.

Market Access

Inflation Reduction Act Impacts: Navigating the New Landscape

The IRA will make many improvements to the Medicare program overall, and many on the pharmaceutical side have been mainly focused on preparing for the Medicare Drug Price Negotiation Program. Download this paper to understand the current timelines and guidance.

Navigating a Drug Launch: Best Practices to De-risk Your Launch Plan

Master drug launch success! Herspiegel shares 4-part blog series on de-risking launch plans. Tap into our go-to-market model now.

The Importance of Building a Strong Portfolio of Products with Co-Positioning

Maximize portfolio impact! Learn key co-positioning strategies for products in our latest whitepaper. Boost performance now.

Patient Services

Designing patient support programs that deliver on their promise

Transform patient outcomes with effective support programs. Learn how to create impactful adherence strategies—start now!

Launch Excellence

Oncology Product Launch Toolkit

Master oncology product launches with key strategies for success. Learn vital planning & collaboration tips. Watch our presentation.

Delivering Cell and Gene Therapies at Scale (VIDEO)

Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.

Launch Excellence

Oncology Product Launch Plan and Execution for Rare Disease Indication

Leading biotech engaged Herspiegel for critical oncology drug launch in a competitive market, showcasing a dedicated, innovative approach.

Inflation Reduction Act Impacts

Uncover how the Inflation Reduction Act revolutionizes Medicare & drug prices. Stay ahead with Herspiegel's insights. Read now.

The Art and Science of Forecasting Drug Launches

Navigate pharma's complex landscape with Herspiegel’s savvy drug launch forecasting. Discover strategies for success. Click to learn more.

Successful Launch of Phase 3 Asset in Different Therapeutic Areas

Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.

Patient Journey and Product Launch Planning – Oncology

Explore Herspiegel's approach to Oncology Patient Journey Mapping for new cancer therapy launches. Learn about our innovative strategies.

Leveraging Archetypes for an Effective Drug Launch Strategy

Unlock personalized drug launch success with Herspiegel's archetype strategies. Dive into tailored planning for impactful market entry.

Identify Rare Disease Launch Archetypes to Determine Your Optimal Launch Approach

Discover the vast impact of rare diseases affecting 30M Americans & the struggle for diagnosis. Dive deeper into their stories.

Four Key Elements of Drug Launch Planning

Master drug launch excellence with our guide on 4 key elements. Download now to define markets, gain insights & strategize your brand.

Early Commercialization for Oncology Start-Up

Join our journey in guiding an oncology start-up towards successful first product launch with expert strategies. Discover our impact.

Patient Services

Transforming Patient Services in Pharma: 5 winning strategies

Revamp your pharma patient services with our top 5 strategies. Elevate care & outcomes. Get the whitepaper now.

Redesigning a Patient Support Program to Successfully Deliver Treatments to Patients with Complex Conditions

Learn how Herspiegel's redesigned patient HUB enhances treatment access for complex conditions. Dive into our case study now.

Commercial Launch Readiness for Pharmaceutical and Biotechnology Start-Ups

Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.

Patient Services

Policy Briefing: Executive Order 14091

Uncover how Executive Order 14091 transforms healthcare for underserved communities & what it means for manufacturers. Learn more.

Patient Services

Patient Services Strategy and Design

Discover top strategies for successful patient services in chronic conditions. Watch our presentation for key insights & case study.

Patient Services

Infrastructure to Enable Holistic Patient Support Services

Learn how to build holistic patient support with insights from Herspiegel & Courier Health. Unlock secrets to patient-centric care now.

Patient Services

Evolving Trends in Patient Services

Discover the latest in patient support trends with Brian Torres in this insightful interview. Visit our Hub for more exclusive resources.

Creating Clear Co-positioning Lanes

Maximize your portfolio's impact with our guide on effective co-positioning strategies for healthcare products. Elevate your launch now.

Proven Pharmaceutical Go-To-Market Model

Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.

Patient Services

Creating Support Programs Where Patients Start, Stay, and Succeed

Gain insights into creating successful patient support programs. Access our exclusive presentations, whitepapers, and case studies. Sign in today.

Launch Excellence

Complete Response Letter Mitigation

Facing a CRL can be daunting. Get insights on trends and tactics to mitigate its impact with our expert paper. Use this guide today.

Market Access

Pre-approval Information Exchange Playbook

Discover how to tailor product launches effectively with our Archetype Playbook. Master your market strategy now.

Market Access

Market Access Trends for Launch Success

Navigate market access complexities for launch success with key trends and insights. Elevate your strategy – Read our report now.

Market Access

5 Ways the Build Back Better Act Will Reduce Costs

Explore 5 key strategies the Build Back Better Act employs to cut drug costs. Essential insights for pharma strategy. Click to learn more.

Articles

Case Studies

White Papers

All Resources

267.759.2130